Northeast Pharmaceutical announced that its wholly-owned subsidiary Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Co., Ltd. and its controlled subsidiary Dongyao Group Shenyang Shide Pharmaceutical Co., Ltd. have had a total of 14 product specifications newly added to the National Essential Medicines List, 2026 edition. These include penicillin sodium for injection, ceftazidime for injection, and azithromycin dry suspension. This move is conducive to the deployment and use of these drugs in medical institutions at all levels, and will have a positive driving effect on the company's long-term development, but the impact on current operating performance is uncertain.
Northeast Pharmaceutical Group Co Ltd14 product specifications added to National Essential Medicines List, boosting long-term deployment and sales potential.